<?xml version="1.0" encoding="UTF-8"?>
<p id="par0135">However, well-designed clinical trials are needed to clarify this point. An Italian study has recently started (called “the Italian Hematology Alliance”) with the main goal of assessing the incidence and potential predictive parameters of mortality of COVID 19 in patients with hematological malignancies.</p>
